The Missed Vital Sign — Execution
Funds United Kingdom women-centered health projects improving vital-sign linked maternal and child outcomes.
The Missed Vital Sign is a $50 million Wellcome Leap program targeting heavy menstrual bleeding (HMB), a condition that affects roughly one in four women yet takes an average of five years to receive a diagnosis or effective treatment. The program is structured as a time-bound, outcomes-focused initiative in which Wellcome Leap acts as a program director rather than a passive grant-maker, setting …
Heavy menstrual bleeding identification, diagnostics, and non-hormonal treatment research aimed at reducing the average duration women experience HMB from five years to five months.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Guides for this application
All guides →Grants for Biotech Startups: NIH, NSF, SBIR/STTR, and Non-Dilutive Funding
A practical guide to grants for biotech startups, including NIH SBIR/STTR, NSF, translational funding, evidence, regulatory readiness, and budgets.
Find grantsGrants for Small Business Startup: Eligibility Checklist
Check whether your deeptech company is eligible for grants for small business startup funding, including SBIR/STTR, EIC Accelerator, and Innovate UK support.
DocumentsGrant Checklist: Application Documents, Forms, and Examples
Use this grant checklist to see the documents, forms, narratives, budgets, evidence, and compliance attachments a grant application may require.
More from Wellcome Leap
All grants from this funder →1kD — Execution
Wellcome Leap · United States
Funds United Kingdom infant brain development research programs focused on translational collaboration.
CARE — Execution
Wellcome Leap · United States
Supports United Kingdom efforts to understand endocrine factors in cognitive aging and dementia risk.
Delta Tissue — Execution
Wellcome Leap · United States
Funds United Kingdom tissue profiling research for improved diagnostics and disease state understanding.
Dynamic Resilience — Execution
Wellcome Leap · United States
Funds healthspan-oriented research in the United Kingdom toward resilient aging and wellness strategies.
Focused Antibiotics
Wellcome Leap · United States
Funds United Kingdom and global teams redesigning antibiotic strategies while preserving gut microbiome health.
FORM
Wellcome Leap · United States
Funds United Kingdom maternal and infant microbiome research to improve long-term health outcomes.
Similar grants
Browse the directory →
ARPA-H Mission Office ISOs
🇺🇸ARPA-H · United States
Supports United States mission teams with boundary-pushing health initiatives beyond existing programme limits.
ASPIRE Reduction-to-Practice (Seed)
🇺🇸NCATS · United States
Supports translational chemistry and automation platform development through university-linked partnerships.
DoW Military Burn, Technology/Therapeutic Development Award
🇺🇸MRDC / CDMRP · United States
Funds turning preclinical burn-care findings into an actual product — a device, a drug, or a clinical practice guideline.
Utilizing the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early Detection Research
NIH · United States
Funds research using a screening trial's biorepository — serial blood samples collected before diagnosis, with decades of matched participant data.
Assay Validation of High Quality Markers for Clinical Studies in Cancer
🇺🇸NIH · United States
Funds two years of analytical validation then three of clinical validation for a cancer biomarker assay that already works on human samples.
SIP Phase 3 — Active Consortia Participation
🇯🇵CSTI Japan · Japan
Funds cross-ministerial Japanese innovation across energy, health, and robotics to strengthen real-world implementation.